Often described as ground zero for the epidemic, the communities of Cabell County and Huntington, W. Va., had opted out of a settlement and lost their case at trial.
The consulting firm offered clients “in-depth experience in narcotics,” from poppy fields to pills more powerful than Purdue’s OxyContin.
We answer a common reader question about the opioid crisis and legalizing drugs.
It was the first time, after years of lawsuits, that the family that owns Purdue Pharma was forced to hear directly from families who had lost loved ones to addiction.
Opioid prescriptions are down, but overdose deaths remain high, and certain patients have lost relief.
And is there anything I can do to find relief?
But they continue to insist on protection from civil liability claims over opioids, an unusual and controversial measure that derailed a previous deal.
Overdoses are increasing at a troubling rate.
The agency threw out previous recommended limits on doses but encouraged “nonopioid therapies” wherever possible.
In “The Hard Sell,” the journalist Evan Hughes tells the story of the rise and fall of Insys Therapeutics — and the larger pharmaceutical industry.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
Two recent rulings rejected the “public nuisance” argument being used in thousands of cases against the industry, with more trials and settlement talks underway.
As doctors and patients worry about the effects of painkillers, therapists are finding they can be a powerful salve for suffering.
Too often, seniors who use opioids become targets for exploitation and abuse.
The Justice Department has been appealing the deal, approved earlier this month.
A professor, a psychiatrist and a nurse react to a Times investigation. Also: A modern Civil War; a more confident child.
The Purdue Pharma bankruptcy case settlement protected the wealthy and ignored those who suffered.
At one time the N.F.L.’s highest-paid defensive player, he left the league after six seasons and fell into a spiral of addiction, homelessness and desolation.
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.
In a rare courtroom appearance, the former Purdue Pharma president and board member was evasive and defiant.
A confidential Justice Department report found the company was aware early on that OxyContin was being crushed and snorted for its powerful narcotic, but continued to promote it as less addictive.
In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are granted broad legal immunity.
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
Cures for a disease that mostly afflicts Black people seem near, but may come too late for Lisa Craig, who lives with an agony like knives stabbing her bones.
Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain.
A decade ago, it was already a crisis. But it feels like its getting worse.
The prosecution on Long Island is one of several across the nation that seek to hold doctors criminally accountable for opioid-related deaths.
The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.
“He made me feel like a drug addict,” Dr. Susan Moore said, accusing a white doctor of downplaying her complaints of pain and suggesting she should be discharged.
The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay its distributors rebates for overdoses.
Parents should not be afraid of managing the child’s pain with opioids when they are needed, but should make sure a child does not have access to leftover doses.
Court filings reveal consultants’ talk of a records purge during the opioid crisis, and shed new light on sales advice given to the billionaire Sackler family and their drug company, Purdue Pharma.
Three distributors and a drug manufacturer have proposed a deal that a majority of states and negotiators for small governments finally seem to like.
The company, which produced OxyContin, faces penalties of $8.3 billion. But families of those addicted are skeptical of the tangible benefits.
The family behind Purdue Pharma made a fortune on the opioid epidemic. Will they ever truly face justice?